Pierre Soubeyran
AuthID: R-00F-J6V
1
TÃTULO: Risk Factors and Outcomes for Patients With Follicular Lymphoma Who Had Histologic Transformation After Response to First-Line Immunochemotherapy in the PRIMA Trial
AUTORES: Clementine Sarkozy; Marek Trneny; Luc Xerri; Nick Wickham; Pierre Feugier; Sirpa Leppa; Pauline Brice; Pierre Soubeyran; Maria Gomes Da Silva; Christiane Mounier; Fritz Offner; Jehan Dupuis; Dolores Caballero; Danielle Canioni; Marlton Paula; Richard Delarue; Pierre Zachee; John Seymour; Gilles Salles; Herve Tilly;
PUBLICAÇÃO: 2016, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 34, NÚMERO: 22
AUTORES: Clementine Sarkozy; Marek Trneny; Luc Xerri; Nick Wickham; Pierre Feugier; Sirpa Leppa; Pauline Brice; Pierre Soubeyran; Maria Gomes Da Silva; Christiane Mounier; Fritz Offner; Jehan Dupuis; Dolores Caballero; Danielle Canioni; Marlton Paula; Richard Delarue; Pierre Zachee; John Seymour; Gilles Salles; Herve Tilly;
PUBLICAÇÃO: 2016, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 34, NÚMERO: 22
2
TÃTULO: Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial Full Text
AUTORES: Gilles Salles; John Francis Seymour; Fritz Offner; Armando Lopez Guillermo; David Belada; Luc Xerri; Pierre Feugier; Reda Bouabdallah; John Vincent Catalano; Pauline Brice; Dolores Caballero; Corinne Haioun; Lars Moller Pedersen; Alain Delmer; David Simpson; Sirpa Leppa; Pierre Soubeyran; Anton Hagenbeek; Olivier Casasnovas; Tanin Intragumtornchai; ...Mais
PUBLICAÇÃO: 2011, FONTE: LANCET, VOLUME: 377, NÚMERO: 9759
AUTORES: Gilles Salles; John Francis Seymour; Fritz Offner; Armando Lopez Guillermo; David Belada; Luc Xerri; Pierre Feugier; Reda Bouabdallah; John Vincent Catalano; Pauline Brice; Dolores Caballero; Corinne Haioun; Lars Moller Pedersen; Alain Delmer; David Simpson; Sirpa Leppa; Pierre Soubeyran; Anton Hagenbeek; Olivier Casasnovas; Tanin Intragumtornchai; ...Mais
PUBLICAÇÃO: 2011, FONTE: LANCET, VOLUME: 377, NÚMERO: 9759
3
TÃTULO: Updated Results of the PRIMA Study Confirms the Benefit of 2-Years Rituximab Maintenance In Follicular Lymphoma Patients Responding to Immunochemotherapy.
AUTORES: Gilles Andre Salles; John Catalano; Pierre Feugier; Fritz C Offner; Reda Bouabdallah; Dolores Caballero; Pauline Brice; Lars Moller Pedersen; Corinne Haioun; David Belada; Alain Delmer; David Simpson; Herve Tilly; Sirpa Leppa; Pierre Soubeyran; Anton Hagenbeek; Olivier Casasnovas; Tanin Intragumtornchai; Christophe Ferme; Maria Gomes da Silva; ...Mais
PUBLICAÇÃO: 2010, FONTE: 52nd Annual Meeting of the American-Society-of-Hematology (ASH) in BLOOD, VOLUME: 116, NÚMERO: 21
AUTORES: Gilles Andre Salles; John Catalano; Pierre Feugier; Fritz C Offner; Reda Bouabdallah; Dolores Caballero; Pauline Brice; Lars Moller Pedersen; Corinne Haioun; David Belada; Alain Delmer; David Simpson; Herve Tilly; Sirpa Leppa; Pierre Soubeyran; Anton Hagenbeek; Olivier Casasnovas; Tanin Intragumtornchai; Christophe Ferme; Maria Gomes da Silva; ...Mais
PUBLICAÇÃO: 2010, FONTE: 52nd Annual Meeting of the American-Society-of-Hematology (ASH) in BLOOD, VOLUME: 116, NÚMERO: 21
INDEXADO EM: 
WOS
WOS